Skip to Content

INV 314 7.5 (Warfarin Sodium 7.5 mg)

Pill with imprint INV 314 7.5 is Yellow, Four-sided and has been identified as Warfarin Sodium 7.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Warfarin is used in the treatment of antiphospholipid syndrome; deep vein thrombosis prophylaxis after knee replacement surgery; deep vein thrombosis prophylaxis after hip replacement surgery; chronic central venous catheterization; deep vein thrombosis, first event and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Warfarin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INV 314 7.5

Warfarin sodium 7.5 mg INV 314 7.5

Warfarin Sodium

Imprint
INV 314 7.5
Strength
7.5 mg
Color
Yellow
Shape
Four-sided
Availability
Prescription only
Drug Class
Coumarins and indandiones
Pregnancy Category
D - Positive evidence of risk - for women with mechanical heart valves, X - Not for use in pregnancy - for other pregnant populations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-0386

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.